DGAT1 and cancer: Thus, we assessed whether cancer stemness can be effectively suppressed by the overall inhibition of TAG turnover by simultaneously treating cells with Atglistatin and A922500—an inhibitor of diacylglycerol O-acyltransferase (DGAT), the enzyme that catalyzes the final step of TAG synthesis [37,38].